Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Cell Physiol ; 178(3): 387-96, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9989785

RESUMO

A new family of signaling intermediates for TGFbeta superfamily members and other growth factors has recently been identified and termed Smads. It has been suggested that the Smad1 subfamily is regulated primarily by the TGFbeta superfamily member bone morphogenetic protein (BMP). Here we demonstrate that TGFbeta induced phosphorylation of endogenous Smad1 in untransformed IECs and that the RI and RII TGFbeta receptors were detectable in Smad1 immunocomplexes. Expression of a dominant-negative mutant of Ras inhibited the ability of TGFbeta to phosphorylate endogenous Smad1. In a separate series of experiments, we have cloned a rat homologue of the drosophila mad gene (termed RSmad1) by screening an intestinal epithelial cell (IEC) cDNA library. By using an in vitro kinase assay with RSmad1 as the substrate, we demonstrate that the TGFbeta receptor complex can directly phosphorylate RSmad1. We show, further, that a dominant-negative mutant of MEK1 inhibited the ability of RSmad1 to induce the TGFbeta-responsive reporter p3TP-Lux in a human breast cancer cell line. Collectively, our data demonstrate that TGFbeta can regulate Smadl and that the Ras and MEK signaling components are partially required for the ability of TGFbeta to regulate Smad1.


Assuntos
Proteínas de Transporte , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Regulação da Expressão Gênica/fisiologia , Quinases de Proteína Quinase Ativadas por Mitógeno , Proteínas Repressoras , Transdução de Sinais/fisiologia , Transativadores/genética , Transativadores/metabolismo , Fator de Crescimento Transformador beta/farmacologia , Proteínas ras/metabolismo , Sequência de Aminoácidos , Animais , Proteínas de Ciclo Celular , Linhagem Celular , Clonagem Molecular , Proteínas de Ligação a DNA/química , Drosophila , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , MAP Quinase Quinase 1 , Masculino , Dados de Sequência Molecular , Proteínas Nucleares/química , Proteínas Nucleares/genética , Especificidade de Órgãos , Fosfoproteínas/química , Fosfoproteínas/genética , Fosforilação , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas Tirosina Quinases/metabolismo , Ratos , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/metabolismo , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Transdução de Sinais/efeitos dos fármacos , Proteínas Smad , Proteína Smad1 , Transativadores/química , Transfecção , Fator de Crescimento Transformador beta/fisiologia
3.
Biochim Biophys Acta ; 1267(1): 1-5, 1995 May 29.
Artigo em Inglês | MEDLINE | ID: mdl-7779864

RESUMO

The effect of ganglioside GM1 on isoproterenol-induced cAMP accumulation was studied in insect Sf9 cells expressing the human beta 1-adrenergic receptor by infection with recombinant baculovirus. When such Sf9 cells were treated with isoproterenol plus IBMX, intracellular cAMP formation increased approximately 10-fold over the basal level. Preincubation of the baculovirus-infected cells with GM1 for 1 h caused a concentration-dependent inhibition of the isoproterenol-induced cAMP accumulation. Phosphatidylserine, GM3, GT1b and a bovine brain ganglioside preparation lacking GM1 did not cause significant inhibition. Forskolin-induced cAMP accumulation was not affected by the GM1 treatment. Inhibition of isoproterenol-induced cAMP formation by GM1 was not observed in Sf9 cells expressing beta 2-adrenergic receptor instead of the beta 1-adrenergic receptor. Binding studies with (-)-[3H]CGP12177 showed that preincubation with GM1 significantly reduced the affinity of antagonist binding to the beta 1-adrenergic receptor. These results suggest that GM1 or related ganglioside structure(s) may function as natural modulator(s) of the beta 1-adrenergic receptor.


Assuntos
Monofosfato de Adenosina/biossíntese , Gangliosídeo G(M1)/metabolismo , Receptores Adrenérgicos beta/metabolismo , Antagonistas Adrenérgicos beta/farmacologia , Animais , Baculoviridae/metabolismo , Linhagem Celular , Humanos , Insetos , Isoproterenol/farmacologia , Propanolaminas/farmacologia , Receptores Adrenérgicos beta/genética , Transfecção
4.
Biochemistry ; 29(9): 2335-42, 1990 Mar 06.
Artigo em Inglês | MEDLINE | ID: mdl-2159799

RESUMO

Evidence is presented for a role of disulfide bridging in forming the ligand binding site of the beta 2-adrenergic receptor (beta AR). The presence of disulfide bonds at the ligand binding site is indicated by "competitive" inhibition by dithiothreitol (DTT) in radioligand binding assays, by specific protection by beta-adrenergic ligands of these effects, and by the requirement of disulfide reduction for limit proteolysis of affinity ligand labeled receptor. The kinetics of binding inhibition by DTT suggest at least two pairs of disulfide-bonded cysteines essential for normal binding. Through site-directed mutagenesis, we indeed were able to identify four cysteines which are critical for normal ligand binding affinities and for the proper expression of functional beta AR at the cell surface. Unexpectedly, the four cysteines required for normal ligand binding are not those located within the hydrophobic transmembrane domains of the receptor (where ligand binding is presumed to occur) but lie in the extracellular hydrophilic loops connecting these transmembrane segments. These findings indicate that, in addition to the well-documented involvement of the membrane-spanning domains of the receptor in ligand binding, there is an important and previously unsuspected role of the hydrophilic extracellular domains in forming the ligand binding site.


Assuntos
Cisteína/metabolismo , Dissulfetos/metabolismo , Espaço Extracelular/metabolismo , Receptores Adrenérgicos beta/metabolismo , Animais , Sítios de Ligação , Ligação Competitiva , Cricetinae , Ditiotreitol/metabolismo , Ditiotreitol/farmacologia , Cinética , Ligantes , Mutação
5.
J Recept Res ; 8(1-4): 7-21, 1988.
Artigo em Inglês | MEDLINE | ID: mdl-2838630

RESUMO

The adenylate cyclase-stimulatory beta 2-adrenergic receptor has been purified to apparent homogeneity from hamster lung. Partial amino acid sequence obtained from isolated CNBr peptides was used to clone the gene and cDNA for this receptor. The predicted amino acid sequence for the hamster beta 2-adrenergic receptor revealed that the protein consists of a single polypeptide chain of 418 aa with consensus N-glycosylation and phosphorylation sites predicted by previous in vitro data. The most striking feature of the receptor protein however, is that it contains seven stretches of hydrophobic residues similar to the proposed seven transmembrane segments of the light receptor rhodopsin. Significant amino acid homology (30-35%) can be found between the hamster beta 2-adrenergic receptor and rhodopsin within these putative membrane spanning regions. Using a hamster beta 2-adrenergic receptor probe, the gene and cDNA for the human beta 2-adrenergic receptor were isolated, revealing a high degree of homology (87%) between the two proteins from different species. Unlike the genes encoding the family of opsin pigments, of which rhodopsin is a member, the genes encoding both hamster and human beta 2-adrenergic receptors are devoid of introns in their coding as well as 5' and 3' untranslated nucleotide sequences. The cloning of the genes and the elucidation of the aa sequences for these G-protein coupled receptors should help to determine the structure-function as well as the evolutionary relationship of these proteins.


Assuntos
Cricetinae/genética , Mesocricetus/genética , Receptores Adrenérgicos beta/genética , Sequência de Aminoácidos , Animais , Clonagem Molecular , DNA/genética , Genes , Humanos , Dados de Sequência Molecular , Conformação Proteica , Rodopsina/genética , Homologia de Sequência do Ácido Nucleico
6.
Proc Natl Acad Sci U S A ; 84(1): 46-50, 1987 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-3025863

RESUMO

We have isolated and sequenced a cDNA encoding the human beta 2-adrenergic receptor. The deduced amino acid sequence (413 residues) is that of a protein containing seven clusters of hydrophobic amino acids suggestive of membrane-spanning domains. While the protein is 87% identical overall with the previously cloned hamster beta 2-adrenergic receptor, the most highly conserved regions are the putative transmembrane helices (95% identical) and cytoplasmic loops (93% identical), suggesting that these regions of the molecule harbor important functional domains. Several of the transmembrane helices also share lesser degrees of identity with comparable regions of select members of the opsin family of visual pigments. We have localized the gene for the beta 2-adrenergic receptor to q31-q32 on chromosome 5. This is the same position recently determined for the gene encoding the receptor for platelet-derived growth factor and is adjacent to that for the FMS protooncogene, which encodes the receptor for the macrophage colony-stimulating factor.


Assuntos
Cromossomos Humanos Par 14 , DNA/metabolismo , Fator de Crescimento Derivado de Plaquetas/genética , Receptores Adrenérgicos beta/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Membrana Celular/metabolismo , Mapeamento Cromossômico , Cricetinae , Cricetulus , Feminino , Humanos , Células Híbridas/metabolismo , Placenta/metabolismo , Gravidez , Conformação Proteica
7.
J Bacteriol ; 134(1): 177-83, 1978 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25883

RESUMO

Growth of Pseudomonas sp. NRRL B3266 in the presence of oleic acid resulted in the induction of two enzymes: oleate hydratase, which produced 10(R)hydroxyoctadecanoate, and hydroxyoctadecanoate dehydrogenase, which catalyzed the oxidized nicotinamide adenine dinucleotide-dependent production of 10-oxooctadecanoate. This latter enzyme was purified to homogeneity and shown to consist of two polypeptide chains of about 29,000 daltons each. The enzyme had a broad substrate specificity, catalyzing the dehydrogenation of a number of 18-carbon hydroxy fatty acids. The kinetic parameters for various 10- and 12-hydroxy fatty acids were similar (Km ca. 5 micron and Vmax ca. 50 to 200 mumol/min per mg of protein). The enzyme also catalyzed the dehydrogenation of unsubstituted secondary alcohols. The effectiveness of these alcohols as substrates was highly dependent on their hydrophobicity, the Km decreasing from 9 mM for 4-heptanol to 7 micron for 6-dodecanol. Inhibition of the enzyme by primary alcohols also showed a dependence on hydrophobicity, the Ki decreasing from 350 mM for methanol to 90 micron for decanol.


Assuntos
Oxirredutases do Álcool/metabolismo , Pseudomonas/enzimologia , Oxirredutases do Álcool/análise , Oxirredutases do Álcool/isolamento & purificação , Álcoois/farmacologia , Aminoácidos/análise , Concentração de Íons de Hidrogênio , Hidroxiácidos/metabolismo , Cinética , Peso Molecular , NAD/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA